Cargando…

Respiratory motion tracking system of hepatocellular carcinoma treatment using FUS

Detalles Bibliográficos
Autores principales:	Fukuda, Hiroyuki, Doba, Nobutaka, Numata, Kazushi, Takeda, Ayako, Hao, Yoshiharu, Nozaki, Akito, Kondo, Masaaki, Chuma, Makoto, Maeda, Shin, Fujii, Tatsuya, Lee, Dongjuin, Koizumi, Norihiro, Tsukihara, Hiroyuki, Mitsuishi, Mamoru, Matsumoto, Yoichiro, Yoshinaka, Kiyoshi, Tanaka, Katsuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489608/ http://dx.doi.org/10.1186/2050-5736-3-S1-P47

Ejemplares similares

Usefulness of 3D slicer for the planning and monitoring of hepatocellular carcinoma treatment using FUS
por: Doba, Nobutaka, et al.
Publicado: (2015)

Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression
por: Kondo, Masaaki, et al.
Publicado: (2017)

Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment
por: Fukuda, Hiroyuki, et al.
Publicado: (2018)

Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study
por: Nozaki, Akito, et al.
Publicado: (2021)

Therapeutic effects of regorafenib after sorafenib monotherapy with advanced hepatocellular carcinoma including Child–Pugh classification B: A retrospective observational study
por: Komiyama, Satoshi, et al.
Publicado: (2020)

High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas
por: Fukuda, Hiroyuki, et al.
Publicado: (2013)

Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
por: Tarao, Kazuo, et al.
Publicado: (2020)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021)

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021)

Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma
por: Tarao, Kazuo, et al.
Publicado: (2021)

Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study
por: Wang, Feiqian, et al.
Publicado: (2022)

Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Ultrasound image based visual servoing for moving target ablation by high intensity focused ultrasound
por: Seo, Joonho, et al.
Publicado: (2016)

Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma
por: Hao, Yoshiteru, et al.
Publicado: (2017)

Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma
por: Wang, Feiqian, et al.
Publicado: (2020)

Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and Resection
por: Wang, Feiqian, et al.
Publicado: (2022)

Differential diagnosis of solid pancreatic lesions using contrast-enhanced three-dimensional ultrasonography
por: Miwa, Haruo, et al.
Publicado: (2014)

Feasible study of MRgFUS of early breast cancer - report of completion of BC006 in Japan
por: Namba, Kiyoshi, et al.
Publicado: (2015)

Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
por: Funaoka, Akihiro, et al.
Publicado: (2021)

Liver Injury and Use of Contrast-Enhanced Ultrasound for Evaluating Intrahepatic Recurrence in a Case of TACE-Refractory Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab Combination Therapy: A Case Report
por: Komiyama, Satoshi, et al.
Publicado: (2021)

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma
por: Chuma, Makoto, et al.
Publicado: (2020)

Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
por: Tanaka, Katsuaki, et al.
Publicado: (1999)

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma
por: Takada, Juichi, et al.
Publicado: (2015)

Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
por: Azuma, Shintaro, et al.
Publicado: (2020)

Author Correction: Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
por: Azuma, Shintaro, et al.
Publicado: (2021)

The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
por: Kawamura, Atsushi, et al.
Publicado: (2022)

Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS
por: Motaln, Helena, et al.
Publicado: (2023)

Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosis
por: Tarao, Kazuo, et al.
Publicado: (2021)

ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation
por: King, Andrew, et al.
Publicado: (2015)

Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain
por: Rogelj, Boris, et al.
Publicado: (2012)

Frameshift peptides alter the properties of truncated FUS proteins in ALS-FUS
por: An, Haiyan, et al.
Publicado: (2020)

ALS-Associated FUS Mutations Result in Compromised FUS Alternative Splicing and Autoregulation
por: Zhou, Yueqin, et al.
Publicado: (2013)

The FUS gene is dual‐coding with both proteins contributing to FUS‐mediated toxicity
por: Brunet, Marie A, et al.
Publicado: (2020)

Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid
por: Fujii, Chikako, et al.
Publicado: (2017)

Preoperative chemoradiotherapy for locally advanced low rectal cancer using intensity-modulated radiotherapy to spare the intestines: a single-institutional pilot trial
por: Sakanaka, Katsuyuki, et al.
Publicado: (2021)

Immune activation and MRgFUS
por: Ferrara, Katherine, et al.
Publicado: (2015)

Development and Validation of a 15-Item Japanese Health Knowledge Test
por: Tokuda, Yasuharu, et al.
Publicado: (2010)

Does ALS‐FUS without FUS mutation represent ALS‐FET? Report of three cases
por: Borrego‐Écija, S., et al.
Publicado: (2018)

FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice
por: Kino, Yoshihiro, et al.
Publicado: (2016)

Different Income Information as an Indicator for Health Inequality among Japanese Adults
por: Fukuda, Yoshiharu, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_g4n6v7rb0476gq7n7ll12enp53